Anti-tumor fusion protein as well as encoding gene and application thereof

Anti-tumor fusion protein as well as encoding gene and application thereof

  • CN 104,151,432 A
  • Filed: 05/14/2013
  • Published: 11/19/2014
  • Est. Priority Date: 05/14/2013
  • Status: Active Application
First Claim
Patent Images

1. an antineoplastic amalgamation protein, is characterized in that, described fusion rotein has following one-level aminoacid sequence structure:

  • Selectively targeted oligopeptides-connection peptides the 1-of EGFR Lidamycin agon albumen-connection peptides 2-(tuftsin) n;

    Wherein, the selectively targeted oligopeptides of described EGFR has the aminoacid sequence shown in SEQ ID NO;

    1, and described Lidamycin agon albumen has the aminoacid sequence shown in SEQ ID NO;

    2, and described tuftsin has the aminoacid sequence shown in SEQ ID NO;

    3;

    And, n=1-3.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×